Trials / Completed
CompletedNCT01607203
Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
Randomised Controlled Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- AZ Jan Palfijn Gent · Academic / Other
- Sex
- Female
- Age
- 38 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Decapeptyl Daily | Decapeptyl 0.2 mg SC once 1day |
| DRUG | pregnyl | 5000 IU SC |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-05-30
- Last updated
- 2015-02-19
- Results posted
- 2015-02-19
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01607203. Inclusion in this directory is not an endorsement.